| تعداد نشریات | 282 |
| تعداد نشریات سازمان | 80 |
| تعداد شماره‌ها | 3,272 |
| تعداد مقالات | 36,132 |
| تعداد مشاهده مقاله | 55,702,303 |
| تعداد دریافت فایل اصل مقاله | 94,486,058 |
Relative Frequency of HTLV-І Infection in Blood Donors in Ahvaz, Southwest of Iran | ||
| Archives of Razi Institute | ||
| مقاله 7، دوره 81، شماره 1، فروردین و اردیبهشت 2026، صفحه 53-58 اصل مقاله (575.89 K) | ||
| نوع مقاله: Original Articles | ||
| شناسه دیجیتال (DOI): 10.66224/ARI.81.1.3182 | ||
| نویسندگان | ||
| Mehdi Parsanahad1؛ Roohangize Nashibi* 2؛ Manoochehr Makvandi1؛ Fateme Ahmadi2؛ Bijan Helli3؛ Zahra Lotfi4 | ||
| 1Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. | ||
| 2Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. | ||
| 3Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. | ||
| 4Department of Infectious Diseases, School of Medicine, Razi Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. | ||
| چکیده | ||
| Introduction: Human T-lymphotropic virus type I (HTLV-I) is recognized as the first human retrovirus. It constitutes a significant health concern in endemic areas, with HTLV-1 primarily disseminated through infected biological fluids, such as blood, breast milk, and semen. Contributory risk factors encompass unprotected sexual intercourse, intravenous drugs use, tissue transplantation, as well as blood and blood component donation. HTLV-I is implicated in two critical pathologies: Adult T-cell leukemia and tropical spastic paraparesis. The geographic prevalence of HTLV-I exhibits global variability, including within the context of Iran. This investigation was undertaken to assess the prevalence of the HTLV-I virus among blood donors in Ahvaz. Materials & Methods: In this cross-sectional analysis, a total of 777 blood donors were enrolled, comprising 771(99.2%) males and 6(0.8%) females, with a mean age of 38.08±8.42 years. All blood specimens were systematically evaluated for HTLV-I antibodies utilizing enzyme-linked immunosorbent assay (ELISA) in accordance with the manufacturer’s protocols. Results: Positive cases were identified through polymerase chain reaction (PCR) analysis utilizing peripheral blood mononuclear cells (PBMC) derived from the positive ELISA blood specimen. Among the 777 blood donors, a single case (0.1%) tested positive for the HTLV-І antibody. The individual in question was a 35-year-old male married with no documented history of blood transfusions, surgical procedures, dialysis, intravenous drug use, phlebotomy, or engagement in high-risk sexual behaviors, either personally or through his spouse. The PCR analysis yielded a negative result. Conclusion: The findings of this investigation indicate that HTLV-І infection is not endemic among blood donors in Ahvaz, and thus, the screening of blood samples for HTLV-І infection in this region does not seem to be warranted. | ||
| کلیدواژه‌ها | ||
| Human T-lymphotropic virus type I (HTLV-І)؛ Blood donors؛ Ahvaz؛ Endemic | ||
| عنوان مقاله [English] | ||
| فراوانی نسبی عفونت HTLV-І در اهداکنندگان خون اهواز، جنوب غرب ایران | ||
|
سایر فایل های مرتبط با مقاله
|
||
| مراجع | ||
|
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980; 77(12):7415-9. [DOI:10.1073/pnas.77.12.7415]
Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, et al. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis. 2005; 191(9):1490-7. [DOI:10.1086/429410]
Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989; 43(2):250-3. [DOI:10.1002/ijc.2910430214]
Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012; 3:388. [DOI:10.3389/fmicb.2012.00388]
Blattner WA, Saxinger C, Riedel D, Hull B, Taylor G, Cleghorn F, et al. A study of HTLV-I and its associated risk factors in Trinidad and Tobago. J Acquir Immune Defic Syndr. 1990; 3(11):1102-8. [PMID]
Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: A population-based seroepidemiology survey. J Clin Virol. 2011; 52(3):172-6. [DOI:10.1016/j.jcv.2011.07.004]
Khameneh ZR, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl. 2008; 19(5):838-41. [PMID]
Baradaran SM, Rostamzade Z, Gharebagh Z, Mehman Navaz A. [Seroprevalence of HTLV‑1/II Infection Among Blood Donors in Urmia (Northwestern Iran) in 2005 (Persian)]. 2005.
Ghaffari J, Naghshvar F, Nazari Z, Farid R, Torabizadeh J, Madani F. Madani F: Seroprevalence of human T-cell lymphotropic virus type 1 infection (HTLV1) in different patients in the north of Iran. Afri J Biotech. 2011; 10(52):10752-5. [Link]
Miller M, Achiron A, Shaklai M, Stark P, Maayan S, Hannig H, et al. Ethnic cluster of HTLV-I infection in Israel among the Mashhadi Jewish population. J Med Virol. 1998; 56(3):269-74. [DOI:10.1002/(sici)1096-9071(199811)56:3<269::aid-jmv16>3.0.co;2-9] [PMID]
Kumar H, Gupta PK. Is seroprevalence of HTLV-I/II among blood donors in India relevant? Indian J Pathol Microbiol. 2006; 49(4):532-4. [PMID]
Uchenna Tweteise P, Natukunda B, Bazira J. Human T-Cell Lymphotropic Virus Types 1 and 2 Seropositivity among Blood Donors at Mbarara Regional Blood Bank, South Western Uganda. Leuk Res Treatment. 2016; 2016(1):1675326. [DOI:10.1155/2016/1675326]
Viana GM de C, Nascimento M do DSB, de Oliveira RAS, Dos Santos AC, Galvão C de S, da Silva MACN. Seroprevalence of HTLV-1/2 among blood donors in the state of Maranhão, Brazil. Rev Bras Hematol Hemoter. 2014; 36(1):50-3. [DOI:10.5581/1516-8484.20140013]
Ma Y, Zheng S, Wang N, Duan Y, Sun X, Jin J, et al. Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in central China. PLoS One. 2013; 8(6):e66795. [DOI:10.1371/journal.pone.0066795] [PMID]
Okoye AE, Ibegbulam OG, Onoh RC, Ugwu NI, Anigbo CS, Nonyelu CE. Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria. J Blood Med. 2015; 6:31-6. [DOI:10.2147/JBM.S65556] [PMID]
Maghsudlu M, Safabakhsh H, Jamili P. Seroepidemiology of human T-cell lymphotropic virus Type-I in blood donors of Northeastern Iran, Sabzevar. Asian J Transfus Sci. 2015; 9(2):203-6. [DOI:10.4103/0973-6247.154255]
Abbaszadegan MR, Gholamin M, Tabatabaee A, Farid R, Houshmand M, Abbaszadegan M. Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol. 2003; 41(6):2593-5. [Link]
Falahi S, Sabahi F, Zainali M, Kiani J, Ranjbari J. Incidence of human T-lymphotropic virus type 1 (HTLV-1) among blood donors from Ilam, Iran. Iran J Virol. 2008; 2(3-4):21-4. [DOI:10.21859/isv.2.3.4.21]
Yahyapour Y, Aghajanipour K, Mir SM, Khademian A, Sadeghi F. Human T-Lymphotropic Virus Type 1 in Blood Donors from Babol County Blood Transfusion Center: A Pilot Study from Northern Iran. Jundishapur J Microbiol. 2017; 10:e13757. [DOI:10.5812/jjm.13757]
Ghaffari J, Kowsarian M, Mahdavi M, Vahid Shahi K, Rafatpanah H, Tafreshian A. Prevalence of HTLV-I infection in patients with thalassemia major in mazandaran, North of Iran. Jundishapur J Microbiol. 2013; 6(1):57-60. [Link]
Salehi M, Shokouhi Mostafavi SK, Ghasemian A, Gholami M, Kazemi-Vardanjani A, Rahimi MK. Seroepidemiology of HTLV-1 and HTLV-2 infection in Neyshabur City, north-Eastern Iran, during 2010-2014. Iran Biomed J. 2017; 21(1):57-60. [DOI:10.18869/acadpub.ibj.21.1.57]
Alavi SM, Etemadi A. HIV/HBV, HIV/HCV and HIV/HTLV-1 co infection among injecting drug user patients hospitalized at the infectious disease ward of a training hospital in Iran. Pak J Med Sci. 2007; 23(4):510-3. [Link]
Ramezani A, Aghakhani A, Banifazl M, Boland-Ghamat Z, Foroughi M, Gachkar L, et al. Frequency of Human T-Cell Lymphotropic Virus (HTLV) Type 1 and 2 Infection in HIV Infected Patients. Iran J Pathol. 2012; 7(1):9-13. [Link]
Ghaffari J, Ebrahimi M, Makhlough A, Mohammadjafari H, Nazari Z. Seroepidemiology of human T-cell lymphotropic virus 1 infection in hemodialysis patients: Should we be concerned about it? Iran J Kidney Dis. 2013; 7(3):187-90. [PMID] | ||
|
آمار تعداد مشاهده مقاله: 823 تعداد دریافت فایل اصل مقاله: 479 |
||
